Name: HUVEC Tube-formation Assay to Evaluate the Impact of Natural Products on Angiogenesis (Video) | JoVE Journal
Uploaded: 2019-06-24T13:00:00.000+00:00
Duration: 6 min 12 s
Description: Learn the HUVEC tube formation assay to evaluate angiogenesis using Ruta graveolens extract on a gelled basement matrix. This method helps researchers study natural compounds in vascular biology.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

This work has been funded by Fondi di Ateneo to Luca Colucci-D&#39;Amato and VALERE Program funds to Maria Teresa Gentile and AIRC fund IG18999 to Maurizio Bifulco.

1. RGWE Preparation
<ol>
	<li>Collect R. graveolens leaves from plants during the spring/summer months under the supervision of a botanist. 
	NOTE: In this case, leaves were collected at the Experimental Section of Medicinal Plants in the Botanical Garden of Naples, Italy5. The plant is spontaneous, perennial, and is present in the Mediterranean regions (Figure 1).</li>
	<li>Weigh 250 g of leaves and finely chop them with scissors.</li>
	<li>Put the leaves in a conical flask and add 1 L of distilled water to 250 g of chopped leaves and bring that to a boil at 110 &#176;C for 60 min. Cover the flask with aluminum foil to avoid excessive evaporation.</li>
	<li>Use 3 mm-funnel filter paper to separate the boiled leaves from the liquid phase that represents the water extract.</li>
	<li>Filter the liquid phase through a 0.22 &#181;m filter, collecting it in a beaker. Cover the beaker with parafilm and freeze the extract at -80 &#176;C overnight.</li>
	<li>Make 10 - 15 holes with a needle in the parafilm and lyophilize the extract in a lyophilizer. Note that it can take a couple of days to obtain the powder.</li>
	<li>Weigh the powder obtained, divide it into aliquots, and store it at 4 &#176;C until necessary. It is possible to store it for a year.</li>
	<li>When necessary for the experiments, prepare a stock solution, diluting the powder with distilled water to a standard concentration of 50 mg/mL. Separate it into small-volume (e.g., 1 mL) aliquots. This preparation can be stored at -20 &#176;C until used but cannot be stored at 4 &#176;C for more than a couple of days because of the oxidations of the molecules. Avoid freeze and thaw.</li>
</ol>
2. Cell Culture
<ol>
	<li>Cultivate HUVECs in endothelial cell growth medium: endothelial basal medium supplemented with 1 &#956;g/mL hydrocortisone and 1 ng/mL epidermal growth factor, 10% FBS, and penicillin/streptomycin at 37 &#176;C in an atmosphere of 5% CO2.</li>
	<li>When 80% confluent, split the cells at the ratio of 1:3 every passage. Use cells from two to five passages, that do not show apparent differences in response to growth factors. After the sixth passage, cells become senescent and do not form tubes on the gelled basement matrix.</li>
</ol>
3. Transfection
<ol>
	<li>When the HUVECs are 70% confluent, transfect them with the desired gene.</li>
	<li>For a 100 mm plate, use 1 &#181;g of empty pCDNA3 vector as control and 1 &#181;g of pCDNA3 vector containing the gene of interest (constitutively active MEK [caMEK], in this case).</li>
	<li>Complex 1 &#181;g of DNA with 3 &#181;L of lipofectamine 2,000, diluted with reduced serum medium (see Table of Materials) to the final volume of 200 &#181;L. Remove the medium from the cells and replace it with 1 mL of fresh complete medium; then, add the transfecting solution to the cells. Incubate the cells in the incubator at 37 &#176;C, with 5% CO2. It is possible to also use other transfection agents different from lipofectamine 2,000, following the manufacturer&#8217;s instructions.</li>
	<li>Add 7 mL of complete fresh medium 3 h after the transfection and, then, further incubate the cells at 37 &#176;C for 24 - 48 h before proceeding with the next assays. The day after the transfection, replace the medium with fresh complete medium.</li>
</ol>
4. Tube Formation Assay
<ol>
	<li>Cool a 96-well plate and pipette tips at 4 &#176;C for 1 h before preparing the gelled basement.</li>
	<li>At the moment of the basement preparation, put the plate on ice (0 &#176;C) and add 50 &#956;L of cold matrix in each well while avoiding the formation of bubbles. Note that the matrix-containing vial should be kept on ice during the procedure since the matrix becomes solid at room temperature.</li>
	<li>Put the plate in the incubator at 37 &#176;C with 5% CO2 for at least 30 min to allow the basement to polymerize.</li>
	<li>In the meantime, harvest the cells. Wash the HUVECs with 1 mL of a 0.25% trypsin/0.53 mM EDTA solution; then, add 2 mL of the trypsin-EDTA solution and incubate at 37 &#176;C for 5 min. Observe the cells under an inverted microscope to verify that the cell layer is completely dispersed. Then, collect the medium in which the cells are suspended and harvest the detached cells by centrifugation at 264 x g for 3 min. Resuspend them in 1 mL of phosphate-buffered saline (PBS).</li>
	<li>To count the cells, add 0.2 mL of the cell suspension to 0.5 mL of PBS and 0.3 mL of 0.4% trypan blue solution. After 5 min at room temperature, count the cells in a B&#252;rker chamber.</li>
	<li>Resuspend the cells in complete medium at the concentration of 2 x 104 cells/50 &#181;L. Seed them onto the gelled basement at the concentration of 2 x 104 cells per well and let them settle on it.</li>
	<li>Pay attention to the number of the cells. Too many or too few cells may not form tubes in the right way on the gelled basement.</li>
	<li>Prepare increasing doses of RGWE (0.01, 0.1, and 1 mg/mL), diluting the stock solution in culture medium or rutin (12, 120, and 300 &#181;g/mL), all in the final volume of 50 &#181;L/well, and add them to 50 &#956;L/well of cell suspension. The final volume in each well will be 100 &#956;L. Prepare four to six wells for each experimental condition. As a control, dilute distilled water (vehicle) in the culture medium at a ratio of 1:50.</li>
	<li>Incubate the cells in the incubator at 37 &#176;C and 5% CO2 for a time ranging from 6 to 24 h.</li>
	<li>Observe the cells within a time range spanning from 6 to 24 h after seeding, using a phase-contrast microscope at a magnification of 10X. HUVECs are able to form tube-like structures within 6 h but it is possible to observe better results after 12 - 18 h. Photograph the tube-like structures on each well and image an average from three to five random fields in each well.</li>
	<li>After the image acquisition, the cells can be detached from the basement matrix and counted to evaluate the effect of the treatment on the number of cells. For each well, remove the medium, add dispase at a concentration of 24 U/mL, and put the plate at 37 &#176;C for 1 h. Then, from each well, collect the medium in which the cells are suspended and harvest the detached cells by centrifugation at 264 x g for 3 min. Resuspend them in 0.2 mL of PBS. To count the cells, add 0.2 mL of cell suspension to 0.5 mL of PBS and 0.3 mL of 0.4% trypan blue solution. After 5 min at room temperature, count the cells in the B&#252;rker chamber.</li>
	<li>To quantify the results of the tube formation assay, it is possible to count the number of branch points in which at least three tubes join. Using the appropriate image software, count for each field in each micrograph the number of branch points and calculate the mean &#177; the standard error (SE) for each experimental condition. Use a two-tailed t-test to evaluate statistical significance.</li>
</ol>

<ol><li>Carmeliet, P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Angiogenesis+in+life%2C+disease+and+medicine%5BTitle%5D)+AND+%22Nature%22%5BJournal%5D)">Angiogenesis in life, disease and medicine.</a> Nature. 438 (7070), 932-936 (2005).</li>
<li>Carmeliet, P., Jain, R. K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Molecular+mechanisms+and+clinical+applications+of+angiogenesis%5BTitle%5D)+AND+%22Nature%22%5BJournal%5D)">Molecular mechanisms and clinical applications of angiogenesis.</a> Nature. 473 (7347), 298-307 (2011).</li>
<li>Ferrara, N., Kerbel, R. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Angiogenesis+as+a+therapeutic+target%5BTitle%5D)+AND+%22Nature%22%5BJournal%5D)">Angiogenesis as a therapeutic target.</a> Nature. 438 (7070), 967-974 (2005).</li>
<li>Ravishankar, D., Rajora, A. K., Greco, F., Osborn, H. M. I. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Flavonoids+as+prospective+compounds+for+anti-cancer+therapy%5BTitle%5D)+AND+%22The+International+Journal+of+Biochemistry+%26+Cell+Biology%22%5BJournal%5D)">Flavonoids as prospective compounds for anti-cancer therapy.</a> The International Journal of Biochemistry & Cell Biology. 45, 2821-2831 (2013).</li>
<li>Gentile, M. T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Ruta+graveolens+water+extract+inhibits+cell-cell+network+formation+in+human+umbilical+endothelial+cells+via+MEK-ERK1%2F2+pathway%5BTitle%5D)+AND+%22Experimental+Cell+Research%22%5BJournal%5D)">Ruta graveolens water extract inhibits cell-cell network formation in human umbilical endothelial cells via MEK-ERK1/2 pathway.</a> Experimental Cell Research. 364 (1), 50-58 (2018).</li>
<li>Butler, M. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Natural+products+to+drugs%3A+natural+product-derived+compounds+in+clinical+trials%5BTitle%5D)+AND+%22Natural+Product+Reports%22%5BJournal%5D)">Natural products to drugs: natural product-derived compounds in clinical trials.</a> Natural Product Reports. 25, 475-516 (2008).</li>
<li>Sulaiman, R. S., Basavarajappa, H. D., Corson, T. W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Natural+product+inhibitors+of+ocular+angiogenesis%5BTitle%5D)+AND+%22Experimental+Eye+Research%22%5BJournal%5D)">Natural product inhibitors of ocular angiogenesis.</a> Experimental Eye Research. 129, 161-171 (2014).</li>
<li>Risau, W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Mechanisms+of+angiogenesis%5BTitle%5D)+AND+%22Nature%22%5BJournal%5D)">Mechanisms of angiogenesis.</a> Nature. 386 (6626), 671-674 (1997).</li>
<li>Trung, N. X. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((In+vitro+models+for+angiogenesis%5BTitle%5D)+AND+%22Journal+of+Science+%26+Development%22%5BJournal%5D)">In vitro models for angiogenesis.</a> Journal of Science & Development. 13 (4), 850-858 (2015).</li>
<li>Ucuzian, A. A., Greisler, H. P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((In+vitro+Models+of+Angiogenesis%5BTitle%5D)+AND+%22World+Journal+of+Surgery%22%5BJournal%5D)">In vitro Models of Angiogenesis.</a> World Journal of Surgery. 31, 654-663 (2007).</li>
<li>Simons, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((American+Heart+Association+Council+on+Basic+Cardiovascular+Sciences+and+Council+on+Cardiovascular+Surgery+and+Anaesthesia.+State-of-the-Art+Methods+for+Evaluation+of+Angiogenesis+and+Tissue+Vascularisation%3A+A+Scientific+Statement+From+the+American+Heart+Association%5BTitle%5D)+AND+%22Circulation+Research%22%5BJournal%5D)">American Heart Association Council on Basic Cardiovascular Sciences and Council on Cardiovascular Surgery and Anaesthesia. State-of-the-Art Methods for Evaluation of Angiogenesis and Tissue Vascularisation: A Scientific Statement From the American Heart Association.</a> Circulation Research. 116 (11), e99-e132 (2015).</li>
<li>Arnaoutova, I., Kleinman, H. K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((In+vitro+angiogenesis%3A+endothelial+cell+tube+formation+on+gelled+basement+membrane+extract%5BTitle%5D)+AND+%22Nature+Protocols%22%5BJournal%5D)">In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract.</a> Nature Protocols. 5 (4), 628-635 (2010).</li>
<li>DeCicco-Skinner, K. L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Endothelial+cell+tube+formation+assay+for+the+in+vitro+study+of+angiogenesis%5BTitle%5D)+AND+%22Journal+of+Visualized+Experiments%22%5BJournal%5D)">Endothelial cell tube formation assay for the in vitro study of angiogenesis.</a> Journal of Visualized Experiments. (91), e51312(2014).</li>
</ol>

The authors have nothing to disclose.

Natural compounds are characterized by a high chemical diversity and biochemical specificity and represent a source of potentially therapeutic molecules. Here, we show how to obtain water extract from the plant R. graveolens and&#160;propose the tube formation assay as an easy-to-perform, reliable, and quantitative method useful to investigate RGWE&#39;s effects on angiogenesis. It is important to boil the R. graveolens leaves for 1 h to be sure to obtain the complete water extract. Boiling for less tha...

Angiogenesis is a physiological process that leads to the formation of new blood vessels from preexisting ones and occurs during embryogenesis and organ growth. In adulthood, angiogenesis is activated only in the cycling ovary, in the placenta during pregnancy, and during wound healing and repair. Angiogenesis depends on the ability of endothelial cells to proliferate, differentiate, and migrate to form an intact vascular network1. However, in several disorders, such as inflammatory, metabolic, and rheumatic diseases, angiogenic processes are altered and angiogenesis becomes excessive. Moreover, uncontrolled angiogenic processes also stimulate tumor progression and metastasis1. For these reasons, in the last decade, research studies are focused on the development of new therapeutic strategies aimed at the inhibition of excessive angiogenesis in cancer, ocular, joint, or skin disorders2,3.
Vascular endothelial growth factor (VEGF) represents the main target of current antiangiogenic therapies4, and several anti-VEGF monoclonal antibodies have been developed and synthesized to prevent excessive angiogenesis. However, these synthetic drugs show severe side effects and have an unfavorable cost-to-benefit ratio5,6. Therefore, it is imperative to find new therapeutic strategies to limit excessive angiogenesis with minimal side effects to complement and combine with currently used drugs. These new drugs can be found among natural products that are characterized by a high chemical diversity and biochemical specificity.
In this article, we propose a simple method to evaluate the impact of the RGWE on the ability of HUVECs to form tubules on a gelled basement matrix in vitro5. Indeed, RGWE is a mixture of secondary metabolites such as flavonoids and polyphenols among which rutin is the major component5. Many of them have been already tested as anti-inflammatory and vasoprotective agents7,8,9,10,11. Moreover, we have recently demonstrated that RGWE, but not rutin, is able to inhibit the HUVEC ability to form tubules on a gelled basement matrix and that this phenomenon is mediated by the MEK-ERK pathway, indicating RGWE as a potential therapeutic tool able to prevent excessive new blood vessel formation5.

<table><tbody><tr><td>HUVEC cells</td><td>Clontech</td><td>C2519A</td><td></td></tr><tr><td>FBS</td><td>Invitrogen</td><td>10270106</td><td></td></tr><tr><td>EBM-2 basal medium</td><td>Clontech</td><td>cc3156</td><td></td></tr><tr><td>Single quot kit- supplemets and growth factors</td><td>clontech</td><td>cc4147</td><td></td></tr><tr><td>Matrigel</td><td>Corning</td><td>354234</td><td></td></tr><tr><td>96-well plates</td><td>Thermo Scientific</td><td>167008</td><td></td></tr><tr><td>15 mL conical tubes</td><td>Sarstedt</td><td>62,554,502</td><td></td></tr><tr><td>10 mL disposable serological pipette</td><td>Sarstedt</td><td>861,254,001</td><td></td></tr><tr><td>5 mL disposable serological pipette</td><td>Sarstedt</td><td>861,253,001</td><td></td></tr><tr><td>1,000 &amp;mu;L pipette</td><td>Gilson</td><td>Pipetman classic</td><td></td></tr><tr><td>100 &amp;mu;L pipette</td><td>Gilson</td><td>Pipetman classic</td><td></td></tr><tr><td>20 &amp;mu;L pipette</td><td>Gilson</td><td>Pipetman classic</td><td></td></tr><tr><td>p1000 pipette tips</td><td>Sarstedt</td><td></td><td></td></tr><tr><td>p20-200 pipette tips</td><td>Sarstedt</td><td>70,760,502</td><td></td></tr><tr><td>Burker chamber</td><td>Fortuna</td><td></td><td></td></tr><tr><td>Trypan blu stain</td><td>Gibco</td><td>15250-061</td><td></td></tr><tr><td>DPBS</td><td>Gibco</td><td>14190-094</td><td></td></tr><tr><td>mill-ex 0.22 &amp;mu;m filters</td><td>Millipore</td><td>SLGS033SS</td><td></td></tr><tr><td>Lyophilizer</td><td>VirTis-SP Scientific</td><td></td><td></td></tr><tr><td>Incubator</td><td>Thermo Scientific</td><td></td><td></td></tr><tr><td>CO&lt;sub&gt;2&lt;/sub&gt;</td><td>AirCos</td><td></td><td></td></tr><tr><td>Pen-Strep</td><td>Gibco</td><td>15070-063</td><td></td></tr><tr><td>100 mm dish</td><td>Sarstedt</td><td>833,902</td><td></td></tr><tr><td>pcDNA3</td><td>Invitrogen</td><td>v79020</td><td></td></tr><tr><td>Lipofectamine-2000</td><td>Invitrogen</td><td>11668027</td><td></td></tr><tr><td>Opti-MEM</td><td>Gibco</td><td>31985070</td><td>Reduced serum medium</td></tr><tr><td>Rutin</td><td>Sigma-Aldrich</td><td>R5143-50G</td><td></td></tr><tr><td>Axiovert 25 microscope</td><td>Zeiss</td><td></td><td></td></tr><tr><td>AmScope MD500 camera</td><td>AmScope</td><td></td><td></td></tr><tr><td>Dispase</td><td>Thermo Scientific</td><td>D4818</td><td></td></tr><tr><td>Lab heater</td><td>Falc</td><td></td><td></td></tr><tr><td>ParaFilm</td><td>American National Can</td><td></td><td></td></tr></tbody></table>

huvec tube-formation assay to evaluate the impact of natural products on angiogenesis

HUVEC Tube-formation Assay to Evaluate the Impact of Natural Products on Angiogenesis

Angiogenesis is a phenomenon that includes different processes, such as endothelial cell proliferation, differentiation, and migration, that lead to the formation of new blood vessels and involve several signal transduction pathways. Here we show that the tube formation assay is a simple in vitro method to evaluate the impact of natural products on angiogenesis and to investigate the molecular mechanisms involved. In particular, in the presence of the water extract of Ruta graveolens (RGWE), endothelial cells are no longer able to form a cell-cell network and that the RGWE effects on human umbilical vein endothelial cell (HUVEC) tube formation is abolished by the constitutive activation of MEK.

To evaluate the influence of RGWE on angiogenesis, we carried out a tube formation assay on a gelled basement matrix. When cultivated on it, HUVECs form tube-like structures that originate from cells that appear elongated and that connect each other to form a cell-cell network (Figure 2). In Figure 3, we show that the number of branches in HUVECs treated with RGWE was significantly lower as compared to the control conditions. Not...

Here, we evaluate the effects of the water extract of Ruta graveolens on vessel network formation by using a tube formation assay on a gelled basement matrix.

Angiogenesis is a phenomenon that includes different processes, such as endothelial cell proliferation, differentiation, and migration, that lead to the ...

huvec-tube-formation-assay-to-evaluate-impact-natural-products-on

Research

JoVE Journal

Developmental Biology

This video protocol illustrates the isolation and culture of human umbilical vein endothelial cells (HUVEC) from human umbilical cord. Once isolated these cells can be used for in vitro angiogenesis assays like the Optimized Fibrin Gel Bead Assay also demonstrated by the Hughes lab.<br...

Isolation of Human Umbilical Vein Endothelial Cells (HUVEC)

This video demonstrates the protocol of an in vitro angiogenesis assay that recapitulates several stages of angiogenesis.  Time-lapse images of sprouting, lumen formation, branching and anastomosis - key features of angiogenesis - are shown.

Optimized Fibrin Gel Bead Assay for the Study of Angiogenesis

A tube formation assay is used to evaluate vascular activity of tumor cells.

A Matrigel-Based Tube Formation Assay to Assess the Vasculogenic Activity of Tumor Cells

Normal adult vascularized mammalian tissue that lacks physiologic angiogenesis and that has not been exposed to surgical intervention is used to study: (i) the initiation and development of angiogenesis following intraperitoneal administration of test agents; and (ii) modification of angiogenesis following systemic administration of selected test agents.

Rat Mesentery Angiogenesis Assay

The tube formation assay is a fast, quantifiable method for measuring in vitro angiogenesis. Endothelial cells are combined with conditioned media and plated on basement membrane extract. Tube formation occurs within hours and newly formed tubules easily quantified.

Endothelial Cell Tube Formation Assay for the In Vitro Study of Angiogenesis

This manuscript describes a tube formation assay to quantify the effects of a given compound or condition on angiogenesis by using endothelial cell tube formation in a controlled environment.

Strategic Endothelial Cell Tube Formation Assay: Comparing Extracellular Matrix and Growth Factor Reduced Extracellular Matrix

miRNA therapeutics have significant potential in regulating cancer progression. Demonstrated here are analytical approaches used for identification of the activity of a combinatorial miRNA treatment in halting cell cycle and angiogenesis.

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Three-dimensional co-culture spheroid angiogenesis assay system is designed to mimic the physiologic angiogenesis. Co-culture spheroids are formed by two human vascular cell precursors, ECFCs and MSCs, and embedded in collagen gel. The new system is effective for evaluating angiogenic modulators, and provides more relevant information to the in vivo study.

Three-dimensional Angiogenesis Assay System using Co-culture Spheroids Formed by Endothelial Colony Forming Cells and Mesenchymal Stem Cells

The method presented here can evaluate the effect of reagents on angiogenesis or vascular permeability in vivo without staining. The method uses dextran-FITC injection via the tail vein to visualize neo-vessels or vascular leakage.

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies

The present protocol allows the recovery of tube-like structures formed in the classical in vitro angiogenesis-tube formation assay where cells, such as trophoblast cells, organize in capillary-like structures over a layer of extracellular basement membrane matrix. The recovered structures are used for RNA and protein isolation for various biochemical analyses.

Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis

Learn the HUVEC tube formation assay to evaluate angiogenesis using Ruta graveolens extract on a gelled basement matrix. This method helps researchers study natural compounds in vascular biology.

HUVEC Tube-formation Assay to Evaluate the Impact of Natural Products on Angiogenesis

Explore More Videos